Showing results (1-10 of 180) with videos related to
Sort By:
Pageof 18
Advances in Experimental Medicine and Biology|November 13, 2012
Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programsDavid I Bellovin, Bikul Das, Dean W FelsherCurrent Opinion in Immunology|April 11, 2013
Noncanonical roles of the immune system in eliciting oncogene addictionStephanie C Casey, David I Bellovin, Dean W FelsherPlos One|June 19, 2008
Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesisShelly Beer, Kimberly Komatsubara, David I Bellovin, et al.Stem Cells (Dayton, Ohio)|June 13, 2012
HIF-2α suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cellsBikul Das, Reza Bayat-Mokhtari, Micky Tsui, et al.Cancer Research|January 26, 2011
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductaseZhongwei Cao, Hua Fan-Minogue, David I Bellovin, et al.Science Translational Medicine|February 1, 2013
CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosisBikul Das, Suely S Kashino, Ista Pulu, et al.Analytical Chemistry|April 9, 2013
Characterization of MYC-induced tumorigenesis by in situ lipid profilingRichard H Perry, David I Bellovin, Emelyn H Shroff, et al.Genes & Cancer|November 2, 2010
MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent MechanismsDean W FelsherCancer Research|May 3, 2008
Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?Dean W FelsherCell Cycle (Georgetown, Tex.)|August 25, 2006
Tumor dormancy: death and resurrection of cancer as seen through transgenic mouse modelsDean W FelsherPageof 18